Search results
Results From The WOW.Com Content Network
The heart rate increases, but generally not above 100 beats/ minute. Total systematic vascular resistance decreases by 20% secondary to the vasodilatory effect of progesterone. Overall, the systolic and diastolic blood pressure drops 10–15 mm Hg in the first trimester and then returns to baseline in the second half of pregnancy. [6]
The parts of the fetal brain that control movement will not fully form until late in the second trimester, and the first part of the third trimester. [7] Control of movement is limited at birth, and purposeful voluntary movements develop during the long period up until puberty. [ 8 ]
The first natural sensation of quickening may feel like a light tapping or fluttering. These sensations eventually become stronger and more regular as the pregnancy progresses. Sometimes, the first movements are mis-attributed to gas or hunger pangs. [3] A woman's uterine muscles, rather than her abdominal muscles, are first to sense fetal ...
The second love teaches us how to trust and be vulnerable again. We love you, second loves! You deserve the biggest hype of all. More from AOL.com: A twenty-something's guide to growing up
The second trimester is defined as starting, between the beginning of week 13 (12 weeks +0 days of GA) [4] and beginning of week 15 (14 weeks + 0 days of GA). [37] It ends at the end of week 27 (26 weeks + 6 days of GA) [ 37 ] or end of week 28 (27 weeks + 6 days of GA).
Human embryonic development or human embryogenesis is the development and formation of the human embryo.It is characterised by the processes of cell division and cellular differentiation of the embryo that occurs during the early stages of development.
Aortocaval compression syndrome, also known as supine hypotensive syndrome, is compression of the abdominal aorta and inferior vena cava by the gravid uterus when a pregnant woman lies on her back, i.e. in the supine position.
The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects). The term "multiple-marker screening test" is sometimes used instead.